"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.
Saturday, 23 November 2019
Trump's New Drug Pricing Plan to be Released Soon -- Pay to Play?
How strange. I was just thinking about why President Trump hasn't said much about drug pricing recently and then this . . . . President Trump tweeted today that he and Secretary Azar will release a plan to lower drug prices by relying on the importation of drugs from other countries. It will be interesting to see which states can import prescription drugs given the upcoming election--he seems to imply only some will be able to do so--expect a challenge to that. His tweet stated:
@SecAzar and I will soon release a plan to let Florida and other States import prescription drugs that are MUCH CHEAPER than what we have now! Hard-working Americans don’t deserve to pay such high prices for the drugs they need. We are fighting DAILY to make sure this HAPPENS...
Posted by Mike Mireles at 00:16:00
Labels: drug pricing, importation, president trump
Subscribe to: Post Comments (Atom)
Post a Comment